PK and Relative Bioavailability of Liquid Metformin vs Tablets in Healthy Adults

Trial statusNot yet recruiting
Trial phasePhase 1
Trial typeInterventional
Biological sexAll
Age18-55
SponsorAspargo Labs, Inc

About this trial

The study will evaluate the pharmacokinetics and relative bioavailability of two liquid metformin formulations (100 mg/mL and 250 mg/mL)

Eligibility criteria

Qualifiers

Male or female adults 18 to 55 years of age, inclusive.

Disqualifiers

Known hypersensitivity or contraindication to metformin or any excipients in the study formulations.

Trial design

Treatments tested in this trial

  • Liquid Metformin 100 mg/mL
  • Liquid Metformin 250 mg/mL

Treatment groups

24 Participants
are divided into 1 treatment group

Locations

This trial has no locations

Sponsors and collaborators